Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/02/2012
PIL Requip Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 07/02/2011 and displayed until 07/02/2012
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 15/04/2010 and displayed until 07/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 26/02/2010 and displayed until 15/04/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/09/2009 and displayed until 26/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 16/12/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 30/03/2007 and displayed until 16/12/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change to information about driving or using machinery
  • Change to Further Information section
  • Change to date of revision
  • Change to manufacturer contact details
  • Change to name of manufacturer
Updated on 09/03/2007 and displayed until 30/03/2007
Reasons for adding or updating:
  • Change to date of revision
  • Company name change or merger
Updated on 09/05/2002 and displayed until 09/03/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 03/05/2001 and displayed until 09/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 20/10/2000 and displayed until 03/05/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 10/08/2000 and displayed until 20/10/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  ropinirole hydrochloride